Regulatory mechanism of NF-κB signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine

Zhongguo Zhongyao Zazhi

Volumn 38, Issue 24, 2013, Pages 4246-4251

  Liu, Hong ^a   Sun, Wei ^b   Wan, Yi Gang ^c   Tu, Yue ^a   Yu, Bing Yin ^a   Hu, Hao ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Jiangsu Province Hospital of Chinese Medicine   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Chronic kidney disease; NF B; Signaling pathway; Traditional Chinese medicine

Indexed keywords

ASTRAGALI RADIX; CHINESE DRUG; DANGGUI BUXUE DECOCTION; GINKGO FOLIUM; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; QILIAN DECOCTION; SCUTELLARIAE RADIX; UNCLASSIFIED DRUG;

CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; GENETIC TRANSCRIPTION; KIDNEY FIBROSIS; KIDNEY INJURY; NEPHRITIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; HUMAN; KIDNEY; METABOLISM; PATHOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC;

ANIMALS; HUMANS; KIDNEY; MEDICINE, CHINESE TRADITIONAL; NF-KAPPA B; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

EID: 84892903354     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20132411     Document Type: Review

References (50)

1. Vidt D G. Inflammation in renal disease[J]. Am J Cardiol, 2006, 97(2A): 20A.
2. Papayianni A. Cytokines, growth factors, and other inflammatory mediators in glomerulonephritis[J]. Ren Fail, 1996, 18(5): 725.
3. Sanz A B, Sanchez-Nino M D, Ramos A M, et al. NF-kappaB in renal inflammation[J]. J Am Soc Nephrol, 2010, 21(8): 1254.
4. Rangan G, Wang Y, Harris D. NF-kappaB signalling in chronic kidney disease[J]. Front Biosci, 2009, 14: 3496.
5. 2001, 20: 188.
6. Morrissey J, Klahr S. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction[J]. Semin Nephrol, 1998, 18(6): 603.
7. Bauerle K T, Schweppe R E, Haugen B R. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion[J]. Mol Cancer, 2010, 9: 117.
8. Pacifico F, Mauro C, Barone C, et al. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas[J]. J Biol Chem, 2004, 279(52): 54610.
9. Hsu L C, Enzler T, Seita J, et al. IL-1beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta[J]. Nat Immunol, 2011, 12(2): 144.
10. Habelhah H. Emerging complexity of protein ubiquitination in the NF-kappaB pathway[J]. Genes Cancer, 2010, 1(7): 735.
11. Wan Y, Gu L, Suzuki K, et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody[J]. Nephron Exp Nephrol, 2005, 99(4): e121.
12. 2009(13): 1546.
13. 2003, 32(6): 548.
14. Yamazaki S, Muta T, Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei[J]. J Biol Chem, 2001, 276(29): 27657.
15. Li X C, Zhuo J L. Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury[J]. Curr Opin Nephrol Hypertens, 2008, 17(1): 37.
16. Aggarwal B B, Takada Y, Shishodia S, et al. Nuclear transcription factor NF-kappa B: role in biology and medicine[J]. Indian J Exp Biol, 2004, 42(4): 341.
17. Renault M A, Jalvy S, Belloc I, et al. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells[J]. Circ Res, 2003, 93(7): 674.
18. Nicholas S B, Kawano Y, Wakino S, et al. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells[J]. Hypertension, 2001, 37(2 Pt 2): 722.
19. 2008(5): 955.
20. 2009(9): 1782.
21. Zhang J, Wang S, Wang K, et al. Herpes simplex virus 1 DNA polymerase processivity factor UL42 inhibits TNF-alpha-induced NF-kappaB activation by interacting with p65/RelA and p50/NF-kappaB1[J]. Med Microbiol Immunol, 2013, 202(4): 313.
22. 2009(3): 195.
23. 2013(1): 33.
24. 2008(1): 15.
25. 2004, 25: 539.
26. 2003, 19(6): 591.
27. 2011(1): 22.
28. 2005(2): 20.
29. 2007(6): 354.
30. 2005(26): 1836.
31. 2010(6): 534.
32. 2008(1): 29.
33. 2006(7): 526.
34. 2008(10): 2172.
35. Cheung G T, Siow Y L, O K. Homocysteine stimulates monocyte chemoattractant protein-1 expression in mesangial cells via NF-kappaB activation[J]. Can J Physiol Pharmacol, 2008, 86(3): 88.
36. Giunti S, Tesch G H, Pinach S, et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells[J]. Diabetologia, 2008, 51(1): 198.
37. 2010(5): 357.
38. 2009(2): 102.
39. 2013(1): 62.
40. 2009(3): 186.
41. 2010(6): 833.
42. 2011(1): 48.
43. D'Amico G, Bazzi C. Pathophysiology of proteinuria[J]. Kidney Int, 2003, 63(3): 809.
44. Huber T B, Kottgen M, Schilling B, et al. Interaction with podocin facilitates nephrin signaling[J]. J Biol Chem, 2001, 276(45): 41543.
45. Hussain S, Romio L, Saleem M, et al. Nephrin deficiency activates NF-kappaB and promotes glomerular injury[J]. J Am Soc Nephrol, 2009, 20(8): 1733.
46. 2011(11): 974.
47. 200910181580.8[P]. 2010-1-13.
48. 2011.
49. 2011(5): 546.
50. 2009(5): 458.